Amedisys, Inc. (AMED) Misses Q2 EPS by 4c; Guides FY13

July 31, 2013 7:11 AM

Amedisys, Inc. (NASDAQ: AMED) reported Q2 EPS of $0.06, $0.04 worse than the analyst estimate ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found